AKT1 and cancer: The KEGG is enriched in 55 pathways, mainly Focal adhesion, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Cell adhesion molecules (CAMs), NF-kappa B signaling pathway, Proteoglycans in cancer, and other pathways associated with tumor occurrence and progression as depicted in Figure 5F; There are 1165 GO-BP enrichment results, of which the first six GO-BP are shown in Figure 5G.